Novel immunological targets in rheumatic diseases: Clues from current therapies

Drug Discovery Today

Volumn 19, Issue 8, 2014, Pages 1155-1160

  D'Acquisto, Fulvio ^a   Rattazzi, Lorenza ^a   Piras, Giuseppa ^a   Galuppo, Maria Letteria ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA; IMMUNOLOGIC FACTOR;

ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOIMMUNITY; AUTOPHAGY; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; DENDRITIC CELL; DRUG MECHANISM; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; NONHUMAN; REVIEW; RHEUMATIC DISEASE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; DRUG EFFECTS; IMMUNOLOGY; RHEUMATIC DISEASES;

ANIMALS; ANTIRHEUMATIC AGENTS; HUMANS; IMMUNOLOGIC FACTORS; RHEUMATIC DISEASES; SIGNAL TRANSDUCTION;

EID: 84906319152     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.06.021     Document Type: Review

References (39)

1. R. Medzhitov et al. Highlights of 10 years of immunology in Nature Reviews Immunology Nat Rev Immunol 11 2011 693 702
2. + T cells Arthritis Res Ther 11 2009 257
3. T.R. Mosmann, and S. Sad The expanding universe of T-cell subsets: Th1, Th2 and more Immunol Today 17 1996 138 146
4. C. Mauri, and A. Bosma Immune regulatory function of B cell Annu Rev Immunol 30 2012 221 241
5. G.J. Adema Dendritic cells from bench to bedside and back Immunol Lett 122 2009 128 130
6. F. Geissmann et al. Development of monocytes, macrophages, and dendritic cells Science 327 2010 656 661
7. Y.K. Lee et al. Developmental plasticity of Th17 and Treg cells Curr Opin Immunol 21 2009 274 280
8. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nat New Biol 231 1971 232 235
9. E. Kopp, and S. Ghosh Inhibition of NF-kappa B by sodium salicylate and aspirin Science 265 1994 956 959
10. M. Hussain et al. Aspirin and immune system Int Immunopharmacol 12 2011 10 20
11. R.S. Hotchkiss et al. Cell death N Engl J Med 361 2009 1570 1583
12. J.Y. Kim et al. Sulfasalazine induces haem oxygenase-1 via ROS-dependent Nrf2 signalling, leading to control of neointimal hyperplasia Cardiovasc Res 82 2009 550 560
13. M. Bertolotto et al. Sulphasalazine accelerates apoptosis in neutrophils exposed to immune complex: role of caspase pathway Clin Exp Pharmacol Physiol 36 2009 1132 1135
14. B. Levine et al. Autophagy in immunity and inflammation Nature 469 2011 323 335
15. M. Pierdominici et al. Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus FASEB J 26 2012 1400 1412
16. S. Swerdlow et al. Apoptosis inhibition by Bcl-2 gives way to autophagy in glucocorticoid-treated lymphocytes Autophagy 4 2008 612 620
17. J.K. Molitoris et al. Glucocorticoid elevation of dexamethasone-induced gene 2 (Dig2/RTP801/REDD1) protein mediates autophagy in lymphocytes J Biol Chem 286 2011 30181 30189
18. X. Xia et al. Glucocorticoid-induced autophagy in osteocytes J Bone Miner Res 25 2010 2479 2488
19. I. Gonzalez-Alvaro et al. Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathway Ann Rheum Dis 68 2009 1644 1650
20. M.C. Claussen, and T. Korn Immune mechanisms of new therapeutic strategies in MS - teriflunomide Clin Immunol 142 2012 49 56
21. E.S. Chan, and B.N. Cronstein Methotrexate - how does it really work? Nat Rev Rheumatol 6 2010 175 178
22. R.N. Maini et al. TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy Clin Exp Rheumatol 11 Suppl 8 1993 173 175
23. C. Deighton et al. Management of rheumatoid arthritis: summary of NICE guidance Br Med J 338 2009 b702
24. M. Feldmann et al. What have we learnt from targeted anti-TNF therapy? Ann Rheum Dis 69 Suppl 1 2010 i97 i99
25. P. Rao et al. IkappaBbeta acts to inhibit and activate gene expression during the inflammatory response Nature 466 2010 1115 1119
26. C. Gabay et al. IL-1 pathways in inflammation and human diseases Nat Rev Rheumatol 6 2010 232 241
27. I. Mitroulis et al. Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome Eur J Intern Med 21 2013 157 163
28. N. Emi Aikawa et al. Immunogenicity of anti-TNF-alpha agents in autoimmune diseases Clin Rev Allergy Immunol 38 2013 82 89
29. W. Tang et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice Science 332 2011 478 484
30. B.S. Youn et al. Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue Diabetes 58 2009 627 636
31. T. Matsubara et al. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue Cell Metab 15 2012 38 50
32. M. Scotece et al. Beyond fat mass: exploring the role of adipokines in rheumatic diseases Sci World J 11 2011 1932 1947
33. K. Ebina et al. Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction Clin Rheumatol 28 2009 445 451
34. M. Otero et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis Ann Rheum Dis 65 2006 1198 1201
35. A.M. Platt et al. Abatacept limits breach of self-tolerance in a murine model of arthritis via effects on the generation of T follicular helper cells J Immunol 185 2010 1558 1567
36. M.H. Wenink et al. Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulation Ann Rheum Dis 71 2012 80 83
37. O.S. Qureshi et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4 Science 332 2011 600 603
38. A.E. Pedersen et al. Monocytes mediate shaving of B-cell-bound anti-CD20 antibodies Immunology 133 2011 239 245
39. B.C. Betts et al. Anti-IL6-receptor-alpha (tocilizumab) does not inhibit human monocyte-derived dendritic cell maturation or alloreactive T-cell response Blood 118 2011 5340 5343